Advertisement

Topics

Latest "Active passive proprioceptive neuromuscular facilitation stretching comparable improving" News Stories

21:20 EDT 26th April 2017 | BioPortfolio

Here are the most relevant search results for "Active passive proprioceptive neuromuscular facilitation stretching comparable improving" found in our extensive news archives from over 250 global news sources.

More Information about Active passive proprioceptive neuromuscular facilitation stretching comparable improving on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Active passive proprioceptive neuromuscular facilitation stretching comparable improving for you to read. Along with our medical data and news we also list Active passive proprioceptive neuromuscular facilitation stretching comparable improving Clinical Trials, which are updated daily. BioPortfolio also has a large database of Active passive proprioceptive neuromuscular facilitation stretching comparable improving Companies for you to search.

Showing "Active passive proprioceptive neuromuscular facilitation stretching comparable improving" News Articles 1–25 of 9,300+

Extremely Relevant

A competitive inhibitory circuit for selection of active and passive fear responses

When faced with threat, the survival of an organism is contingent upon the selection of appropriate active or passive behavioural responses. Freezing is an evolutionarily conserved passive fear response that has been used extensively to study the neuronal mechanisms of fear and fear conditioning in rodents. However, rodents also exhibit active responses such as flight under natural conditions. The...


Relevant

Nucleolus forms via combination of active and passive processes

Researchers at Princeton found that the nucleolus, a cellular organelle involved in RNA synthesis, assembles in part through the passive process of phase separation – the same type of process that causes oil to separate from water. The study, published in the journal Proceedings of the National Academy of Sciences, is the first to show that this happens in living, intact cells.

Stretching: Focus on flexibility

Stretching may benefit your exercise routine. Here's how to do it safely.


Passive smoking—acrolein inhibits immune response, hence accelerating tumour growth

The World Health Organisation (WHO) estimates that every year 600,000 deaths are caused by passive smoking worldwide and, in Austria alone, two or three people a day die as a result of passive smoking. In a study recently published in Scientific Reports, researchers from MedUni Vienna and the Messerli Research Institute have, for the first time, identified the organic compound acrolein (acrylic al...

Passive and active roles of fat-free mass in the control of energy intake and body composition regulation

Passive smoking: Acrolein inhibits immune response, hence accelerating tumor growth

The World Health Organization (WHO) estimates that every year 600,000 deaths are caused by passive smoking worldwide. Now researchers have, for the first time, identified the organic compound acrolein (acrylic aldehyde) as one of the main causes of failure of the immune defense to tumors due to passive smoking.

Fund managers placed on negative by Moody’s

Investors have been served a bleak outlook by ratings agency Moody’s (NYSE:MCO) on Tuesday. The agency has shifted its outlook for the global asset management industry from “stable” to “negative” as the growth of passive investment strategies continues to threaten fees in the industry. The ratings agency said increased regulation and “underwhelming” performance from active manage...

Intraoperative Stretching Micro Breaks Enhance Surgeon Performance

Dr Lowenfels comments on a study examining the mental and physical effects of surgeons incorporating targeted stretching micro breaks intraoperatively, published in Annals of Surgery. Medscape General Surgery

GreatCall Acquires Healthsense to Expand Senior Care Market Footprint

Connected health for active aging provider GreatCall Inc. has acquired Healthsense, a provider of of passive remote monitoring services for the senior care, managed care and home care.  Healthsense remote monitoring service is based on industry-leading passive technology that track activities of daily living (ADLs). For GreatCall the acquisition will expand its portfolio of connected health ... ...

Catalyst Pharmaceuticals’ neuromuscular drug succeeds in seven-patient trial

Catalyst Pharmaceuticals said its experimental drug to treat patients with a severe form of myasthenia gravis (MG), a debilitating neuromuscular disease, met the main goals of a study.

Catalyst Pharma's neuromuscular drug succeeds in study

(Reuters) - Catalyst Pharmaceuticals Inc said on Wednesday its experimental drug to treat patients with a severe form of myasthenia gravis (MG), a rare neuromuscular disease, met the main goals of a study.

BRIEF-Baillie Gifford & Co reports 7.25% passive stake in Dexcom Inc as of Dec 31, 2016

* Reports 7.25 percent passive stake in Dexcom Inc as of 31 December 2016 - SEC filing Source text (http://bit.ly/2jwYmFB) Further company coverage:

In Greece's tobacco culture, passive smoke a serious problem

Nearly two-thirds of Greeks are inhaling someone else's tobacco smoke on a daily basis, making Greece the worst nation in the European Union in exposing its people to the health risks of passive smoking.

BRIEF-BEUTEL, GOODMAN & CO REPORTS 14.12 PCT PASSIVE STAKE IN MERUS LABS

* REPORTS 14.12 PERCENT PASSIVE STAKE IN MERUS LABS INTERNATIONAL INC AS OF DEC 31, 2016 - SEC FILING Source text (http://bit.ly/2iWQuA0) Further company coverage:

BRIEF-BB Biotech AG reports 5.2 pct passive stake in Macrogenics Inc

* BB Biotech AG - reports 5.2 percent passive stake in Macrogenics Inc as of Dec 28 - SEC Filing Source text - http://bit.ly/2iK1MXK Further company coverage:

BRIEF-CVI INVESTMENTS REPORTS 9.9 PERCENT PASSIVE STAKE IN ENTEROMEDICS

* REPORTS 9.9 PERCENT PASSIVE STAKE IN ENTEROMEDICS INC AS OF JAN. 18 - SEC FILING Source text (http://bit.ly/2kpqkSH) Further company coverage:

Horizon Pharma drug fails key study in rare neuromuscular disease

Dec 8 (Reuters) - Horizon Pharma Plc said its drug, Actimmune, failed the main goal in a late-stage study involving patients with Friedreich's ataxia (FA), a rare, degenerative neuromuscular disorder that has no approved treatments.

UPDATE 1-Horizon Pharma drug fails key study in rare neuromuscular disease

Dec 8 (Reuters) - Horizon Pharma Plc said its drug, Actimmune, failed the main goal in a late-stage study involving patients with Friedreich's ataxia (FA), a rare, degenerative neuromuscular disorder that has no approved treatment.

BRIEF-Broadfin Capital LLC reports 10.7 pct passive stake in Avadel Pharma - SEC filing

* Broadfin Capital LLC discloses 10.7 percent passive stake in Avadel Pharmaceuticals PLC as of January 3, 2017 - SEC filing Source text - (http://bit.ly/2hXOGX6) Further company coverage:

Horizon Pharma Drug Fails Study in Rare Neuromuscular Disease

Horizon Pharma Plc said its drug, Actimmune, failed the main goal in a late-stage study involving patients with Friedreich's ataxia (FA), a rare, degenerative neuromuscular disorder that has no approved treatment. Reuters Health Information

BRIEF-Sorrento Therapeutics reports 5.9 pct passive stake in Medovex

* Sorrento Therapeutics Inc reports 5.9 percent passive stake in Medovex Corp as of December 5 - sec filing Source text for Eikon: [ID:http://bit.ly/2huYaUP] Further company coverage:

BRIEF-Mathew Arens reports 6.6 pct passive stake in Tearlab Corp

* Mathew Arens reports 6.6 percent passive stake in Tearlab Corp as of December 31 - SEC filing Source text- http://bit.ly/2juNO8E Further company coverage:

CORRECTED-BRIEF-Sabby Management reports 5.79 pct passive stake in Amedica Corp

* Sabby Management LLC reports 5.79 percent passive stake in Amedica Corp as of Jan 19 - sec filing Source text : http://bit.ly/2iOZAda Further company coverage:

BRIEF-Christopher Brown reports 7.5 pct passive stake in Genvec

* Christopher Brown reports 7.5 percent passive stake in Genvec Inc as of January 24 - sec filing Source text : http://bit.ly/2jRXvBb Further company coverage:

BRIEF-D. E. Shaw & Co reports 5 pct passive stake in Biocryst pharma- sec filing

* As of Jan 4 - D. E. Shaw & Co. L.P. Reports 5 Pct Passive Stake In Biocryst Pharmaceuticals Inc SEC filing Source text for Eikon: Further company coverage:


Quick Search
Advertisement
 

News Quicklinks